Quadrature Capital »

Acumen Pharmaceuticals shares owned by Quadrature Capital

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $104k 49k 2.11

More positions owned by Quadrature Capital

Advanced Micro Devices (AMD)
UnitedHealth (UNH)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Canadian Natl Ry (CNI)
Sandisk Corp (SNDK)
Asml Holding N V N Y Registry Shs (ASML)
Ge Vernova (GEV)
Tesla Motors (TSLA)
Stellantis SHS (STLA)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Booking Holdings (BKNG)
Agnico (AEM)
Lockheed Martin Corporation (LMT)

View all positions for Quadrature Capital

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
FMR
Vanguard Group
Knollwood Investment Advisory
Alyeska Investment Group
ADAR1 Capital Management
Laurion Capital Management
Pathstone Holdings
Hudson Bay Capital Management
Millennium Management
Citadel Advisors
Two Sigma Advisers
Renaissance Technologies

View all funds holding Acumen Pharmaceuticals